Harvard Bioscience, Inc. announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The Company expects to realize overall annual run rate savings of approximately $4 million beginning in the second quarter of 2024. The Company also expects second quarter restructuring-related charges of approximately $0.5 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.82 USD | 0.00% | +7.30% | -28.60% |
Apr. 09 | Harvard Bioscience Reducing Headcount | MT |
Apr. 09 | Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.60% | 166M | |
+7.62% | 218B | |
+6.70% | 183B | |
+11.94% | 134B | |
+24.60% | 106B | |
-2.66% | 61.12B | |
+4.81% | 50.89B | |
+11.55% | 51.26B | |
-1.09% | 40.3B | |
+26.82% | 32.05B |
- Stock Market
- Equities
- HBIO Stock
- News Harvard Bioscience, Inc.
- Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth